All tested compounds exhibited selective inhibition of the tumour-associated hCA isoforms IX and XII with activities in the sub-micromolar or low micromolar range, whereas the off-target cytosolic isoforms hCA I and II were not significantly inhibited by these compounds. The gene discussed is CYP24A1; the disease is neoplasm.